Table 2.
Indications |
Acute coronary syndrome (STEMI and NSTEMI) |
Aortocoronary bypass surgery |
Other surgeries of the heart and the big vessels |
Heart and lung transplantation |
Chronic heart failure (NYHA stage II, III) |
PCI |
Stable coronary heart disease |
Pulmonary hypertension |
Peripheral artery occlusive disease (claudicatio intermittens) |
Prevention in motivated high risk patients (SCORE: 10-year risk of cardiovascular death of >5%; PROCAM: coronary event of >20%) |
Electrophysiological intervention |
Implantation of a cardiac pacemaker or a defibrillator |
Hemodynamically stable arrhythmia |
Sustained ventricular tachycardia or cardiac arrest |
Contraindications |
Unstable angina pectoris |
Heart failure (NYHA IV) |
Acute endomyocarditis or other acute infections |
Recent pulmonary artery embolism or phlebothrombosis |
Hemodynamically relevant arrhythmia |
Critical obstructions of the left ventricular outflow tract |
Patients that cannot be rehabilitated because of physical, psychological or mental limitations |
NSTEMI non-STEMI, NYHA New York Heart Association, PCI percutaneous coronary intervention, SCORE Systematic Coronary Risk Evaluation, PROCAM Prospective Cardiovascular Münster Study, STEMI ST segment elevation myocardial infarction